Crossmark

Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice

Published Online: 2022-01-18

Published Print: 2022-02

Authors

Fayolle, Martin

Lehmann, Sylvain https://orcid.org/0000-0001-6117-562X
Delaby, Constance
Funding

Funding for this research was provided by:

internal funding in the framework of the clinical laboratory
License Information

Text and Data Mining valid from 2022-01-18

Version of Record valid from 2022-01-18
More Information

Article History

Received: 31 August 2021

Accepted: 13 November 2021

First Online: 18 January 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: All the dosages are covered by the prescription of the physicians for CJD detection. The Biobank was officially registered and ethically approved.

Document is current